Separation of Hepatitis C genotype 4a into IgG-depleted and IgG-enriched fractions reveals a unique quasispecies profile

Virology Journal

Volumn 5, Issue , 2008, Pages

  Moreau, Isabelle ^a   O'Sullivan, Hilary ^a   Murray, Caroline ^a   Levis, John ^a   Crosbie, Orla ^a   Kenny Walsh, Elizabeth ^a   Fanning, Liam J ^a  

^a Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN G; HEPATITIS C ANTIBODY;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; GENE INSERTION; GENOTYPE; HEPATITIS C VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PROTEIN DEPLETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRION; CLASSIFICATION; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS C; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PHYLOGENY; SEQUENCE ALIGNMENT; VIROLOGY;

HEPATITIS C VIRUS;

AMINO ACID SEQUENCE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOGLOBULIN G; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; PHYLOGENY; SEQUENCE ALIGNMENT;

EID: 53249090243     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-5-103     Document Type: Article

References (27)

1. The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection? DG Bowen CM Walker, J Hepatol 2005 42 408 417 10.1016/j.jhep.2004.12.013 15710225
2. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. E Kenny-Walsh, N Engl J Med 1999 340 1228 1233 10.1056/NEJM199904223401602 10210705
3. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. S Chevaliez JM Pawlotsky, World J Gastroenterol 2007 13 2461 2466 17552030
4. Molecular virology of hepatitis C virus (HCV): 2006 update. V Brass D Moradpour HE Blum, Int J Med Sci 2006 3 29 34 16614739
5. Hepatitis C viral life cycle. T Suzuki K Ishii H Aizaki T Wakita, Adv Drug Deliv Rev 2007 59 1200 1212 10.1016/j.addr.2007.04.014 17825945
6. Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy. H Le Guillou-Guillemette S Vallet C Gaudy-Graffin C Payan A Pivert A Goudeau F Lunel-Fabiani, World J Gastroenterol 2007 13 2416 2426 17552024
7. Sequence diversity of hepatitis C virus: implications for immune control and therapy. J Timm M Roggendorf, World J Gastroenterol 2007 13 4808 4817 17828811
8. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. SC Ray YM Wang O Laeyendecker JR Ticehurst SA Villano DL Thomas, J Virol 1999 73 2938 2946 10074143
9. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. F Penin C Combet G Germanidis PO Frainais G Deleage JM Pawlotsky, J Virol 2001 75 5703 5710 11356980 10.1128/JVI.75.12.5703-5710.2001
10. Early steps of the hepatitis C virus life cycle. J Dubuisson F Helle L Cocquerel, Cell Microbiol 2008 10 821 827 10.1111/j.1462-5822.2007.01107.x 18081727
11. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. B Bartosch G Verney M Dreux P Donot Y Morice F Penin JM Pawlotsky D Lavillette FL Cosset, J Virol 2005 79 8217 8229 15956567 10.1128/JVI.79.13.8217-8229.2005
12. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. P Andre F Komurian-Pradel S Deforges M Perret JL Berland M Sodoyer S Pol C Brechot G Paranhos-Baccala V Lotteau, J Virol 2002 76 6919 6928 12072493 10.1128/JVI.76.14.6919-6928.2002
13. Correlation between relative number of circulating low-density hepatitis C virus particles and disease activity in patients with chronic hepatitis C. K Hino K Fujii M Korenaga C Murakami M Okazaki M Okuda K Okita, Dig Dis Sci 1997 42 2476 2481 10.1023/A:1018800225815 9440623
14. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. YK Shimizu M Hijikata A Iwamoto HJ Alter RH Purcell H Yoshikura, J Virol 1994 68 1494 1500 8107212
15. Antibody-dependent enhancement of hepatitis C virus infection. K Meyer M Ait-Goughoulte ZY Keck S Foung R Ray, J Virol 2008 82 2140 2149 18094180 10.1128/JVI.01867-07
16. Comparison of amplification enzymes for Hepatitis C Virus quasispecies analysis. SJ Polyak DG Sullivan MA Austin JY Dai MC Shuhart KL Lindsay HL Bonkovsky AM Di Bisceglie WM Lee C Morishima DR Gretch, Virol J 2005 2 41 15847697 10.1186/1743-422X-2-41
17. A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2. M Gerotto F Dal Pero S Loffreda FB Bianchi A Alberti M Lenzi, Blood 2001 98 2657 2663 10.1182/blood.V98.9.2657 11675335
18. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. O Kalinina H Norder S Mukomolov LO Magnius, J Virol 2002 76 4034 4043 11907242 10.1128/JVI.76.8.4034-4043.2002
19. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. S Noppornpanth TX Lien Y Poovorawan SL Smits AD Osterhaus BL Haagmans, J Virol 2006 80 7569 7577 16840336 10.1128/JVI.00312-06
20. New natural intergenotypic (2/5) recombinant of hepatitis C virus. F Legrand-Abravanel J Claudinon F Nicot M Dubois S Chapuy-Regaud K Sandres-Saune C Pasquier J Izopet, J Virol 2007 81 4357 4362 17267503 10.1128/JVI.02639-06
21. Evolution of the hypervariable region of hepatitis C virus. DB Smith, J Viral Hepat 1999 6 Suppl 1 41 46 10.1046/j.1365-2893.1999.00010.x 10760034
22. Independent evolution of hypervariable regions of HIV-1 gp120: V4 as a swarm of N-Linked glycosylation variants. E Castro M Belair GP Rizzardi PA Bart G Pantaleo C Graziosi, AIDS Res Hum Retroviruses 2008 24 106 113 10.1089/aid.2007.0139 18275355
23. Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1. C Li D Candotti JP Allain, J Virol 2001 75 12412 12420 11711631 10.1128/JVI.75.24. 12412-12420.2001
24. Viral population estimation using pyrosequencing. N Eriksson L Pachter Y Mitsuya SY Rhee C Wang B Gharizadeh M Ronaghi RW Shafer N Beerenwinkel, PLoS Comput Biol 2008 4 e1000074 18437230 10.1371/journal.pcbi.1000074
25. Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: divergence over time. HJ Lin LB Seeff L Barbosa FB Hollinger, Hepatology 2001 34 424 429 10.1053/jhep.2001.26635 11481629
26. Evaluation of a new-generation line-probe assay that detects 5' untranslated and core regions to genotype and subtype hepatitis C virus. R Nadarajah GY Khan SA Miller GF Brooks, Am J Clin Pathol 2007 128 300 304 10.1309/RBAAC0HJFWRJB1HD 17638666
27. Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a. I Moreau J Levis O Crosbie E Kenny-Walsh LJ Fanning, Virol J 2008 5 78 18613968 10.1186/1743-422X-5-78